Voyager Therapeutics, Inc., a biotechnology company, focuses on the human genetics for the cure of neurological diseases. Its product pipeline includes VY1706, a tau silencing gene therapy and VY7523, an anti-tau antibody program for the tr...
Leadership
Alfred W. Sandrock Jr., M.D., Ph.D.
President, CEO & Director
Robin Swartz
Principal Financial Officer, Treasurer, Chief Business Officer & COO
Krystof Bankiewicz M.D., Ph.D.Founder
Founder
Mark A. Kay M.D., Ph.D.Founder
Founder
Amy Quinlan
Principal Accounting Officer
Todd Carter Ph.D.
Chief Scientific Officer
Gregory Shiferman
Senior VP, General Counsel & Secretary
Trista Morrison
Chief Corporate Affairs Officer & Chief of Staff to the CEO
